<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>7(1)</volume><submitter>Thorenoor N</submitter><pubmed_abstract>We determined expression of 83 long non-coding RNAs (lncRNAs) and identified ZFAS1 to be significantly up-regulated in colorectal cancer (CRC) tissue. In cohort of 119 CRC patients we observed that 111 cases displayed at least two-times higher expression of ZFAS1 in CRC compared to paired normal colorectal tissue (P &lt; 0.0001). By use of CRC cell lines (HCT116+/+, HCT116-/- and DLD-1) we showed, that ZFAS1 silencing decreases proliferation through G1-arrest of cell cycle, and also tumorigenicity of CRC cells. We identified Cyclin-dependent kinase 1 (CDK1) as interacting partner of ZFAS1 by pull-down experiment and RNA immunoprecipitation. Further, we have predicted by bioinformatics approach ZFAS1 to sponge miR-590-3p, which was proved to target CDK1. Levels of CDK1 were not affected by ZFA</pubmed_abstract><journal>Oncotarget</journal><pagination>622-37</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4808022</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Long non-coding RNA ZFAS1 interacts with CDK1 and is involved in p53-dependent cell cycle control and apoptosis in colorectal cancer.</pubmed_title><pmcid>PMC4808022</pmcid><pubmed_authors>Kretz M</pubmed_authors><pubmed_authors>Faltejskova-Vychytilova P</pubmed_authors><pubmed_authors>Hombach S</pubmed_authors><pubmed_authors>Mlcochova J</pubmed_authors><pubmed_authors>Svoboda M</pubmed_authors><pubmed_authors>Slaby O</pubmed_authors><pubmed_authors>Thorenoor N</pubmed_authors></additional><is_claimable>false</is_claimable><name>Long non-coding RNA ZFAS1 interacts with CDK1 and is involved in p53-dependent cell cycle control and apoptosis in colorectal cancer.</name><description>We determined expression of 83 long non-coding RNAs (lncRNAs) and identified ZFAS1 to be significantly up-regulated in colorectal cancer (CRC) tissue. In cohort of 119 CRC patients we observed that 111 cases displayed at least two-times higher expression of ZFAS1 in CRC compared to paired normal colorectal tissue (P &lt; 0.0001). By use of CRC cell lines (HCT116+/+, HCT116-/- and DLD-1) we showed, that ZFAS1 silencing decreases proliferation through G1-arrest of cell cycle, and also tumorigenicity of CRC cells. We identified Cyclin-dependent kinase 1 (CDK1) as interacting partner of ZFAS1 by pull-down experiment and RNA immunoprecipitation. Further, we have predicted by bioinformatics approach ZFAS1 to sponge miR-590-3p, which was proved to target CDK1. Levels of CDK1 were not affected by ZFA</description><dates><release>2016-01-01T00:00:00Z</release><publication>2016 Jan</publication><modification>2025-04-19T01:26:52.945Z</modification><creation>2019-03-27T03:10:18Z</creation></dates><accession>S-EPMC4808022</accession><cross_references><pubmed>26506418</pubmed><doi>10.18632/oncotarget.5807</doi></cross_references></HashMap>